Rating History for LENZ Therapeutics Inc (LENZ) by BofA Securities

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/12/2026 Jason Gerberry Downgrade Neutral
(Buy)
7.00
(31.00)
5.21
(4.72)
-9.4% Details